CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

DBVTDBV Technologies S.A.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $11.76 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-31 · Mohideen Pharis (Chief Medical Officer) · SELL
  • 2026-02-02 · Mohideen Pharis (Chief Medical Officer) · SELL
  • 2025-12-19 · EPIC Bpifrance (Other) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders77
Shares held21,144,530
Value$336.93M
Percent of shares outstanding7.14%
As of quarter end2026-06-30
RECENT NEWS
  • DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
DBV Technologies S.A. (DBVT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit